Free equity investment tool of Japanese companies

Credit Rating Analysis

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

Dai-ichi Kogyo Seiyaku

イサム塗料

SEIKO PMC

日華化学

Nihon Tokushu Toryo

TOC

kikusui chemical industries

小池酸素工業

SHOEI

IBIDEN

NICHIBAN

MEC

Showa Denko

ISE CHEMICALS

サンエー化研

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Renesas Electronics

KIKUSUI ELECTRONICS etc.

KIKUSUI ELECTRONICS etc.

日本アビオニクス

日本アビオニクス

Credit Rating Analysis: 医学生物学研究所 (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

Credit Rating (Bankruptcy Risk): 医学生物学研究所 (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2013-03-31	A	Credit is high, but affected by biz environs.	¥ 6 B 5.51%	¥ 319 M 3.23%	¥ 213 M -33.01%

Financial Timeline

Date	2012-12-31  (Third quarter )	2013-03-31  (Annual )	2013-06-30  (First quarter )	2013-09-30  (Second quarter )
Credit Rating	BB	A	BB	BB
Total Assets	¥ 8 B	¥ 13 B	¥ 13 B	¥ 12 B
Net Assets	¥ 4 B	¥ 9 B	¥ 8 B	¥ 8 B

Financial Statement Risk Analysis: 医学生物学研究所 (Annual ) (Consolidated )

Special note

Net sales has increased 5 consecutive terms. The performance is good.

The change of Net income is going too far. The management situation is unstable.

Cash(¥ 6 B) is more than the total liabilities(¥ 4 B). It is a very steady fiscal base!

[Date: 2013-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is decrease )
Net Income (¥ 213 M) is first term Net Income (¥ 318 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (3.08％) is first term Net Profit Margin (4.85％) less , there is a possibility that the profitability has deteriorated.

Dividend
Under the situation of Net Income (¥ 213 M) & Operating Cash Flow (¥ 351 M) , Dividend (¥ -68 M) is paid.

Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 6 B) is first term (¥ 6 B) more, however Operating Cash Flow (¥ 351 M) is first term (¥ 670 M) less , there is a possibility that the financing has deteriorated very much.

[Date: 2012-03-31]  Danger : Warning : Caution : Good

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -424 M) & Financial Cash Flow (¥ -229 M) is a minus, Operating Cash Flow (¥ 670 M) is a plus,

Dividend
Under the situation of Net Income (¥ 318 M) & Operating Cash Flow (¥ 670 M) , Dividend (¥ -68 M) is paid.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 393 M) is Sales first term ratio (¥ 312 M) more , there is a possibility that the non-performing asset was increased.

[Date: 2011-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is minus or 0 )
Net Income (¥ -112 M) is minus or 0, so , there is a possibility that the management situation is severe.

Management Risk (*Net Income is decrease )
Net Income (¥ -112 M) is first term Net Income (¥ 266 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-1.79％) is first term Net Profit Margin (4.38％) less , there is a possibility that the profitability has deteriorated.

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -394 M) & Financial Cash Flow (¥ -160 M) is a minus, Operating Cash Flow (¥ 599 M) is a plus,

Dividend Risk
Under the situation of Net Income (¥ -112 M) & Operating Cash Flow (¥ 599 M), Dividend (¥ -68 M) is paid.

Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 6 B) is first term (¥ 6 B) more, however Operating Cash Flow (¥ 599 M) is first term (¥ 629 M) less , there is a possibility that the financing has deteriorated very much.

[Date: 2010-03-31]  Danger : Warning : Caution : Good

Management Risk (*Gross Income is decrease )
Gross Income (¥ 2 B) is first term Gross Income (¥ 2 B) less , there is a possibility that the management situation has stagnated and deteriorated

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -226 M) & Financial Cash Flow (¥ -452 M) is a minus, Operating Cash Flow (¥ 629 M) is a plus,

Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 6 B) is first term (¥ 5 B) more, however Operating Cash Flow (¥ 629 M) is first term (¥ 737 M) less , there is a possibility that the financing has deteriorated very much.

[Date: 2009-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is minus or 0 )
Net Income (¥ -1 B) is minus or 0, so , there is a possibility that the management situation is severe.

Dividend Risk
Under the situation of Net Income (¥ -1 B) & Operating Cash Flow (¥ 737 M), Dividend (¥ -69 M) is paid.

Overinvestment Risk (*Investment Cash Flow confirmed content)
Net Income (¥ -1 B) is a minus, the cashflow of Operating Cash Flow (¥ 737 M) is smaller than Investment Cash Flow (¥ -1 B) , there is a possibility of the overinvestment.

Credit Rating (Bankruptcy Risk): 医学生物学研究所 (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2013-03-31	A	Credit is high, but affected by biz environs.	¥ 5 B 3.25%	¥ 304 M -16.02%	¥ 232 M -9.72%

Financial Timeline

Date	-  (First quarter )	-  (Second quarter )	-  (Third quarter )	2013-03-31  (Annual )
Credit Rating	-	-	-	A
Total Assets	-	-	-	¥ 13 B
Net Assets	-	-	-	¥ 9 B

Financial Statement Risk Analysis: 医学生物学研究所 (Annual ) (Non-Consolidated )

Special note

Net sales has increased 5 consecutive terms. The performance is good.

The change of Net income is going too far. The management situation is unstable.

Cash(¥ 5 B) is more than the total liabilities(¥ 3 B). It is a very steady fiscal base!

[Date: 2013-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is decrease )
Net Income (¥ 232 M) is first term Net Income (¥ 257 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (3.90％) is first term Net Profit Margin (4.46％) less , there is a possibility that the profitability has deteriorated.

Dividend
Under the situation of Net Income (¥ 232 M) & Operating Cash Flow (-) , Dividend (¥ -68 M) is paid.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 361 M) is Sales first term ratio (¥ 188 M) more , there is a possibility that the non-performing asset was increased.

[Date: 2012-03-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 257 M) & Operating Cash Flow (-) , Dividend (¥ -68 M) is paid.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 315 M) is Sales first term ratio (¥ 309 M) more , there is a possibility that the non-performing asset was increased.

[Date: 2011-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is minus or 0 )
Net Income (¥ -51 M) is minus or 0, so , there is a possibility that the management situation is severe.

Management Risk (*Net Income is decrease )
Net Income (¥ -51 M) is first term Net Income (¥ 372 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-0.93％) is first term Net Profit Margin (7.16％) less , there is a possibility that the profitability has deteriorated.

Dividend
Under the situation of Net Income (¥ -51 M) & Operating Cash Flow (-) , Dividend (¥ -68 M) is paid.

[Date: 2010-03-31]  Danger : Warning : Caution : Good

Management Risk (*Gross Income is decrease )
Gross Income (¥ 2 B) is first term Gross Income (¥ 2 B) less , there is a possibility that the management situation has stagnated and deteriorated

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 138 M) is Sales first term ratio (¥ 67 M) more , there is a possibility that the non-performing asset was increased.

[Date: 2009-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is minus or 0 )
Net Income (¥ -2 B) is minus or 0, so , there is a possibility that the management situation is severe.

Dividend
Under the situation of Net Income (¥ -2 B) & Operating Cash Flow (-) , Dividend (¥ -69 M) is paid.

Related Information: 医学生物学研究所 (Annual )

Statement Type

Annual : 医学生物学研究所

First quarter : 医学生物学研究所

Second quarter : 医学生物学研究所

Third quarter : 医学生物学研究所

Analysis Menu

Outline : 医学生物学研究所

Statement : 医学生物学研究所

Rating : 医学生物学研究所

Indicator : 医学生物学研究所

Download : 医学生物学研究所

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Aichi - EDIUNET Prefectures

Aichi名古屋市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
医学生物学研究所	4557	OSE JASDAQ	Chemicals	3	Annual	A

Related Company

FUMAKILLA (Sales ¥ 22 B)

Mitsubishi Gas Chemical (Sales ¥ 467 B)

堺化学工業 (Sales ¥ 79 B)

日華化学 (Sales ¥ 31 B)

MAEZAWA KASEI INDUSTRIES (Sales ¥ 21 B)

ARAKAWA CHEMICAL INDUSTRIES (Sales ¥ 67 B)

TOC (Sales ¥ 20 B)

EARTH CHEMICAL (Sales ¥ 125 B)

Showa Denko (Sales ¥ 739 B)

サンエー化研 (Sales ¥ 32 B)

Miysubishi Rayon (Sales ¥ 456 B)

Dai-ichi Kogyo Seiyaku (Sales ¥ 51 B)

Sekisui Plastics (Sales ¥ 101 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .